Tecnotree (TEM1V) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Mar, 2026Executive summary
Q3 2024 was challenging due to muted order intake in Q1 and significant currency headwinds, but cost-cutting and a focus on free cash flow led to improved financial performance in Q2 and Q3.
Revenue grew 11% year-over-year in constant currency for the first nine months of 2024, with EBIT up 28% in constant currency terms.
Strategic focus is on mature and higher-margin markets (Europe, America), increasing revenue share and reducing exposure to volatile currencies.
Partnerships with SI partners like HCLTech and new product innovations, including GenAI social commerce agent, are expected to drive further growth.
Order backlog remained strong at EUR 75.1 million, with a 77% increase in orders received from Q2 to Q3 2024.
Financial highlights
Q3 2024 net sales were EUR 19.0 million, down 11.2% year-over-year; constant currency sales were EUR 20.2 million.
EBIT in Q3 2024 was EUR 5.0 million (EUR 6.5 million in constant currency), up 43% from Q2 but down from EUR 6.2 million in Q3 2023.
Free cash flow improved to EUR 1.7 million in Q3 2024, marking the second consecutive positive quarter.
CapEx to sales ratio was 11% in Q3 2024, trending toward 10-12% guidance for 2025.
DSO days improved from 170 in Q2 to 153 in Q3.
Outlook and guidance
2024 guidance: 2%-7% revenue growth and 7%-15% EBIT growth in constant currency.
Free cash flow guidance for H2 2024 is EUR 2-5 million; annual free cash flow for 2025 projected to exceed EUR 3 million.
CapEx to sales expected to be 10%-12% by 2025; receivable days targeted at 100-140.
Dividend policy introduced: 10% of free cash flow to be paid as dividends from 2025.
FX exposure to be reduced from 35% to 10%-15% over three years.
Latest events from Tecnotree
- Order backlog up 6%, positive Q2 cash flow, and 2024 growth guidance reaffirmed.TEM1V
Q2 202416 Mar 2026 - Record order backlog, margin expansion, and strong cash flow achieved despite FX and receivable risks.TEM1V
Q4 202526 Feb 2026 - 4% constant currency revenue growth, 33% margin, and board fee cut despite FX and market risks.TEM1V
Q4 20242 Dec 2025 - Q1 2025 delivered 4% revenue growth, positive cash flow, and margin expansion.TEM1V
Q1 202528 Nov 2025 - Record order backlog, margin gains, and positive cash flow drive upgraded full-year outlook.TEM1V
Q2 202523 Nov 2025 - Sixth quarter of positive FCF, record backlog, and margin growth guidance maintained.TEM1V
Q3 20253 Nov 2025